Natixis’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,043
| Closed | -$290K | – | 1240 |
|
|
2022
Q3 | $290K | Hold |
15,043
| – | – | ﹤0.01% | 898 |
|
|
2022
Q2 | $383K | Sell |
15,043
-97,616
| -87% | -$2.49M | ﹤0.01% | 919 |
|
|
2022
Q1 | $2.9M | Buy |
112,659
+30,209
| +37% | +$777K | 0.01% | 662 |
|
|
2021
Q4 | $3.45M | Sell |
82,450
-23,593
| -22% | -$988K | 0.01% | 639 |
|
|
2021
Q3 | $4.62M | Buy |
+106,043
| New | +$4.62M | 0.02% | 565 |
|
|
2021
Q2 | – | Sell |
-173,110
| Closed | -$8.88M | – | 1083 |
|
|
2021
Q1 | $8.88M | Sell |
173,110
-9,602
| -5% | -$492K | 0.03% | 400 |
|
|
2020
Q4 | $4.89M | Buy |
+182,712
| New | +$4.89M | 0.02% | 516 |
|